CTVA in three months: buy, wait or sell?
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
- Buy / Wait / Sell rating
- 3-month target price
- Bear · Base · Bull
- vs. the market
What happened with CTVA today?
No read yet
Uses news and trading volume to explain the day’s move and how it relates to the market.
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
Corteva’s larger business is Seed, which develops and supplies commercial seeds with characteristics intended to improve yields and withstand weather, pests and disease. Its other major business, Crop Protection, sells products that control weeds, insects and disease and support crop health. Almost all revenue comes from product sales to farmers, distributors and manufacturers. Its Pioneer seed brand reaches farmers through independent sales representatives who also provide advice throughout the growing season.
Sales follow planting seasons, so weather and planting delays affect when farmers buy and which products they need. Most corn hybrids and soybean varieties Corteva sells contain biotechnology traits licensed from other companies, making continued access to those licenses important. Seeds containing biotechnology traits and crop protection products also need regulatory approval in each market before they can be produced, used or sold.
Corteva has announced plans to split Seed and Crop Protection into separate publicly traded companies. That remains a proposed separation, subject to approvals and other conditions.
The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.
Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.
Corteva’s results hinge on farmers’ spending on seed and crop protection and competition with Bayer, BASF and Syngenta—major rivals absent from this list.
FMC competes with Corteva globally for farmers’ spending on insecticides, herbicides, biological products and seed treatments that protect crops. FMC’s sales of insecticides and herbicides, which make up most of its product lines, offer a window into the crop-protection market Corteva also serves.
Bioceres Crop Solutions Corp. both competes with Corteva for farmers’ purchases of crop-protection products and seed technologies and supplies Corteva through its Rizobacter business, which formulates and produces products for it. Bioceres’ crop-protection revenue offers a view of the overlapping business, while news about Rizobacter’s work for Corteva bears directly on their supplier relationship.
FMC Corporation earningsFMC
FMC’s report will show how farmers are spending on insecticides and herbicides, offering a read on demand for the crop-protection products FMC and Corteva both sell.
Look at FMC’s insecticide and herbicide sales. Strength would suggest farmers are still buying crop-protection products, supporting demand in the market Corteva also serves. Weakness would point to pressure on farmer spending and a tougher sales environment for Corteva’s Crop Protection business.
Corteva, Inc. earningsThis company
Corteva’s report will show whether farmers’ purchases of both seed and crop-protection products are supporting sales across the business.
Read Seed and Crop Protection sales together. Growth in both would show farmer demand reaching both sides of Corteva’s business. If growth comes from only one, demand in the other remains a concern; overall sales growth would not mean both businesses are strengthening.